Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategies
| Autor: | Di Noia, V., D’Aveni, A., D’Argento, E., Rossi, S., Ghirardelli, P., Bortolotti, L., Vavassori, V., Bria, E., Ceresoli, G.L. |
|---|---|
| Zdroj: | In ESMO Open December 2021 6(6) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|